Gene therapy shows great promise to treat both acquired and inherited diseases.Numerous gene delivery systems based on viral and nonviral vectors have been developed to protect plasmid DNA and facilitate cell binding and internalization.Nevertheless
it is still a challenge to deliver DNA to target cell population and particular location by injection or systematic delivery due to the immune responses and DNA complex aggregation
degradation
and clearance from the tissue.Polymers loaded with gene or vector/gene complexes can realize the controlled release of gene delivery systems and direct gene delivery to target tissues.This technique
known as “substratemediated transfection"
overcomes the extracelluar barriers of gene delivery
sustains the gene release
decreases the toxicity and consequently improves the gene transfection efficiency.Most commonly
the polymers for the controlled release of gene delivery systems are biodegradable polymers.Using these polymers
a variety of formulations of controlled release systems
including nanoparticles
microspheres
implantable matrices and scaffolds
can be fabricated.This review focuses on the recent developments in the polymers used for the controlled release of gene delivery systems
with emphasis on their applications in gene therapy and tissue engineering.These polymers are classified as natural polymers and their derivatives such as collagen
atelocollagen
gelatin
fibrin
glycosaminoglycans
chitosan
alginate
and agarose
and synthetic polymers including poly(lactide-co-glycolide)
poly(lactic acid)
functionalized poly(lactic acid)
poly(orthoester)s
poly( β-amino ester)s
polyanhydrides
polyurethanes and poly(ethylene-co-vinylacetate).Looking to the future
through exquisite adjusting of the chemical and physical characteristics of the polymers
optimally engineered properties may be created to gain greater control over gene expression and cell growth.